Keyword Connections

disease progression

Journals

2

1 Journal of Alzheimer's disease : JAD

2 Translational vision science & technology

Research Groups

0

No Research Group Connected

Bibliographies

48

1 Performance of Antenatal Diagnostic Criteria of Twin-Anemia-Polycythemia Sequence

2 Scores of Health-Related Quality of Life Questionnaire Worsen Consistently in Patients of COPD: Estimating Disease Progression over 30 Years by SReFT with Individual Data Collected in SUMMIT Trial

3 Performance of Antenatal Diagnostic Criteria of Twin-Anemia-Polycythemia Sequence

4 multi-state models for defining degrees of chronicity related to hiv-infected patient therapy adherence modelos multi-estado para la determinación de los grados de cronicidad, de acuerdo con la adhesión del paciente infectado por el vih modelos multiestado para determinação dos graus de cronicidade de acordo com a adesão de paciente infectado pelo hiv

5 treatment for mycobacterium avium complex lung disease

6 the application of minimally invasive devices with nanostructured surface functionalization: antisticking behavior on devices and liver tissue interface in rat

7 ash dieback on sample points of the national forest inventory in south-western germany

8 systemic radical scavenger treatment of a mouse model of rett syndrome: merits and limitations of the vitamin e derivative trolox

9 genesis – the generic simulation system for modelling state transitions

10 comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment

11 application of texture analysis to dat spect imaging: relationship to clinical assessments

12 prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the tempo 3:4 clinical trial

13 etiology and pediatric chronic kidney disease progression: taiwan pediatric renal collaborative study

14 the role of ace gene polymorphism in rapidity of progression of focal segmental glomerulosclerosis.

15 Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression.

16 Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm.

17 Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiative—a prospective cohort study

18 [Enhancing monitoring of disease progression-remote sensoring in multiple sclerosis].

19 A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy.

20 Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer's disease.

21 Neuropsychiatric Correlates of Small Vessel Disease Progression in Incident Cognitive Decline: Independent and Interactive Effects.

22 CD4 and total lymphocyte counts as predictors of HIV disease progression

23 CD4 and total lymphocyte counts as predictors of HIV disease progression

24 new insights about treg and th17 cells in hiv infection and disease progression

25 age and environment influences on mouse prion disease progression: behavioral changes and morphometry and stereology of hippocampal astrocytes

26 change in content of multiple cytokines in the serum of mods mice and its relationship with disease progression

27 cellular transplantation alters the disease progression in becker’s muscular dystrophy

28 parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effects

29 a pilot trial of pioglitazone hcl and tretinoin in als: cerebrospinal fluid biomarkers to monitor drug efficacy and predict rate of disease progression

30 circadian rhythm dysfunction accelerates disease progression in a mouse model with amyotrophic lateral sclerosis

31 interstitial fluid flow in cancer: implications for disease progression and treatment

32 association between angiogenesis soluble factors and disease progression markers in chronic hepatitis c patients asociación entre factores angiogénicos solubles y marcadores de progresión de la enfermedad en pacientes con hepatitis crónica c

33 rapid disease progression of liver metastases following resection in a liver-transplanted patient with probable lynch syndrome – a case report and review of the literature

34 the angiogenic activity of ascites in the course of ovarian cancer as a marker of disease progression

35 changes in b-cell counts and percentages during primary hiv infection associated with disease progression in hiv-infected men who have sex with men: a preliminary study

36 blood transcriptional signatures for disease progression in a rat model of osteoarthritis

37 non-monotonic reorganization of brain networks with alzheimer’s disease progression

38 extracellular vesicles as modulators of tumor microenvironment and disease progression in glioma

39 Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group

40 Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets

41 Clonal dominance patterns of CD8 T cells in relation to disease progression in HIV-infected children

42 Micronutrients and Human Immunodeficiency Virus Type 1 Disease Progression among Adults and Children

43 Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?

44 Gingival inflammation and subgingival calculus as determinants of disease progression in early-onset periodontitis

45 A Convolutional Neural Network Approach to Quantify Lung Disease Progression in Patients with Fibrotic Hypersensitivity Pneumonitis (HP).

46 Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis.

47 Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

48 Endotoxin Activity Assay as a Novel Predictor of Disease Progression in Patients With Mild Cholangitis.